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F.occ   : Father’s occupation 
M.occ   :  Mother’s occupation 
M.occ H W   : House wife 
HIV(F)   : HIV status of father 
HIV(M)   : HIV status of mother 
HIV(F) 0   : not known 
HIV(F) 1   : Positive 
HIV(M) 0   : Not known 
HIV(M) 1   : Positive 
PREV BT   : History of previous blood transfusion 
PREV BT 0   : No 
PREV BT 1   : Yes 
GLA    : Generalized lymphadenopathy 
HSM    : Hepato spleenomegaly 
PER.PNEU   : Persistent pneumonia 
M B I    : Multiple bacterial infection 
EP.TB   : Extra pulmonary tuberculosis 
FEVER   : Fever for more than one month 
COUGH   : Chronic cough 
CHR. DIARR.  : Chronic diarrhea 
WASTING   : Wasting syndrome 
ORAL THR   : Oral thrush 
R B I    : Recurrent bacterial infection 
GEN DER   : Generalized dermatitis 
SYMPTOM 0  : Absent 
SYMPTOM  1  : Present 
ELISA STATUS 1  : Positive 
ELISA STATUS 2  : Negative 
 
 
 
 
 
ABBREVIATIONS 
 
 
HIV  : Human immunodeficiency virus 
AIDS  : Acquired  Immuno Deficiency  Syndrome 
L I P  : Lymphoid Interstitial Pneumonia 
P C P  : Pneumocystis Carinii Pneumonia 
ELISA : Enzyme Linked Immuno Sorbent Assay 
PCR  : Polymerised Chain Reaction 
BAL  : Broncho Alveolar Lavage 
ART  : Anti retroviral therapy 
ARI  : Acute respiratory tract infection  
CDC  : Centre for disease control 
MAI  : Mycobacterium avium intracellulare 
WHO  : World health organisation 
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 PROFORMA 
Name: 
Age / sex: 
Address: 
Father’s education, occupation,income: 
Mother’s education, occupation,income: 
Socio – economic status: 
Mother’s HIV status known / not: 
If known, took treatment / not: 
Father’s HIV status known / not: 
Previous history of blood transfusion: 
History of early neonatal death of unknown etiology: 
COORDINATES OF THE CURVE 
Test Result Variable(s): age  
Positive if Greater Than or 
Equal To(a) 
Sensitivity 1 - Specificity 
2.00 1.000 1.000 
3.50 .983 1.000 
4.50 .922 1.000 
5.50 .914 1.000 
6.50 .862 .917 
7.50 .845 .917 
8.50 .836 .833 
9.50 .802 .833 
11.00 .793 .833 
13.50 .750 .833 
16.50 .733 .833 
21.00 .664 .667 
27.00 .586 .667 
31.00 .569 .417 
34.00 .560 .417 
39.00 .466 .333 
45.00 .466 .250 
50.00 .336 .167 
53.00 .328 .167 
57.00 .319 .167 
63.00 .293 .167 
69.00 .284 .167 
78.00 .207 .083 
87.00 .181 .083 
93.00 .164 .083 
102.00 .112 .083 
114.00 .069 .083 
126.00 .026 .000 
138.00 .009 .000 
145.00 .000 .000 
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INTRODUCTION 
Children of today are youth of tomorrow. If we allow the HIV / AIDS 
epidemic to slowly but surely wipe away this precious generation from the face 
of the earth, we are going to be sorry in the future. This will impact our nation, 
continent and the world at large. It will adversely affect the health statistics, the 
economic growth and above all the morale of nations. As on today 
approximately 40 million people live with HIV infection worldwide of which 
one third are aged between 15 to 24 years. More than 90% of these patients live 
in developing countries that neither have adequate resources nor the required 
infrastructure to tackle this problem1. 
Today India has approximately 4 million people living with HIV 
infection. Six states namely, Maharashtra, TamilNadu, Andhra Pradesh, 
Karnataka, Manipur and Nagaland are high prevalence states. They have more 
than 1% seroprevalence of HIV infection among pregnant women attending 
antenatal clinic. These states are doing relatively well in their childhood health 
statistics at present. However HIV related mortality could upset all gains 
achieved in last couple of decades with efforts like promotion of breastfeeding, 
ARI control programme, diarrhea control programme, immunization, etc1. 
Twenty eight million deliveries occur in India annually. The average 
HIV prevalence in these pregnant women is 0.5%.  This means 1.4 lakh 
deliveries occur in HIV infected women. Without any intervention, 30 % of 
these HIV infected women transmit HIV to their babies. It means 40,000 babies 
are HIV infected vertically in India annually1. Pediatric AIDS constitutes 2 % 
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of all HIV infected cases in developed countries as compared to 15 – 20 % in 
developing countries. In India women and children constitutes 50 % of all HIV 
infected patients. 
The diagnostic procedures for HIV are not available at all centers and 
needs pre test and post test counseling. 
The present study aims to find the utility of clinically directed selective 
screening to diagnose HIV infection in hospitalized children. 
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REVIEW OF LITERATURE 
MODES OF TRANSMISION 
Most of the HIV infections in children are vertically transmitted i.e. 
acquired from mothers. Blood and blood products, however, remain an 
important source and are responsible for infection in 10 % – 30 % of total cases 
in the developing countries2. Some of the mothers also acquire HIV through 
blood transfusion and transmit the infection to their babies3.                        
HIV EXPOSURE IN INFANTS AND YOUNG CHILDREN 
Mother to child transmission (MTCT) is by far the most significant 
route of transmission of HIV infection in children below the age of 15 years. In 
2005 alone, 700,000 children were reported to have acquired HIV infection4. 
HIV can be transmitted during pregnancy, during child birth or breastfeeding. 
Without intervention, the risk of transmission from an infected mother to her 
child ranges from 15 % - 25 % in developed countries and from 25 % - 45 % in 
developing countries. This difference is largely attributed to breast feeding 
practices.   
Estimated risk and timing of MTCT in the absence of intervention 
{Adapted from Kevin De Cock paper}: 
During pregnancy (5 – 10 %), during labour  and delivery ( 10 – 15 %), 
during breast feeding (5 – 20 %), overall without breast feeding (15 – 25 %), 
overall with breast feeding to 6 months (20 – 35 %), overall with breast feeding 
to 18 – 24 months (30 – 45 %).              
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NATURAL HISTORY OF VERTICALLY TRANSMITTED HIV 
INFECTION 
The clinical course of vertical HIV–1 infection is highly variable, but 
before the widespread use of antiretroviral therapy, two general patterns of 
survival were described. Approximately 10 – 20 % of infants experienced rapid 
progression of disease and died of AIDS related complication by 4 years of 
age. The mean survival time for the remaining 80 – 90 % infected children was 
approximately 9 to 10 years5. 
In a cohort of infants followed from birth, by 12 months of age 83 % 
had shown some sign of HIV disease, 74 % had progressed to category A, 55 
% to category B, 21 % to category C and 6% to death6. Hepatomegaly and 
Lymphadenopathy were the most common category A signs during the first 6 
months of life. 
In another cohort study, category C events or deaths were estimated for 
20 % of perinatally infected infants in the first year of life, with approximately 
5 % succumbing per year thereafter7. 
Analysis of data from pediatric spectrum of disease project in the USA 
showed that the mean time spent by perinatally infected children in each stage 
were: N,10 months;  A,4 months; B,65 months; and C,34 months5. In this 
study, it was estimated that a child born with HIV infection had a 50 % chance 
of severe signs or symptoms by 5 years of age, and a 75% chance of surviving 
to 5 years of age. The estimated mean time from birth to stage C was 6.6 years, 
and the estimated mean survival time was 9.4 years. This study highlighted that 
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perinatally infected children progress to moderate symptoms in the second year 
of life and then remain moderately symptomatic for more than half of their 
expected life span. This clearly underscores the need for their clinical care 
before the onset of AIDS. 
In an African study, the estimated risk of death among perinatally 
infected children at 2 and 5 years of age was 45 % and 62 % respectively; 
median survival time was 12.4 months8. This study observed that early 
infection, early onset of HIV related conditions , failure to thrive and 
generalized lymphadenopathy were associated with subsequent risk of death, 
whereas, LIP was predictive of a milder illness. Thus the prognosis appears to 
be poorer in the African children. 
There is no Indian data to describe the natural history of HIV infection 
in Indian children. 
CLINICAL MANIFESTATIONS  
Clinical manifestations depend on the severity of immunosuppression. 
These, in the initial stages may be non-specific and consists of failure to thrive, 
recurrent fever, diarrhoea and respiratory infections. Children may have 
hepatosplenomegaly, lymphadenopathy, neurological manifestations and 
recurrent bacterial infections. In contrast to adults, who present more frequently 
with distinct HIV associated conditions, infected children in developing 
countries present with a disease spectrum that is similar to uninfected children3. 
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The centre for disease control and prevention (CDC), USA has classified 
clinical features of pediatric HIV infection into four clinical categories for 
children below 13 years of age9. Once classified, a child cannot be reclassified 
into a less severe category even if the child’s clinical status improves such as in 
case of immune reconstitution following institution of ART or resolution of 
clinical event. 
1. Category N, describes asymptomatic children without signs of 
symptoms is considered to be the result of HIV infection or who have 
only one of the condition listed in Category A.  
2. Category A: children classified as category A should have two or more 
mild symptoms of HIV–related conditions such as : lymphadenopathy, 
hepatomegaly, splenomegaly, dermatitis, parotitis, recurrent upper 
respiratory tract infection such as sinusitis,otitis media etc., children 
with category B or C clinical conditions do not remain in category A 
even if they have multiple Category A conditions. 
3. Category B defines children who are moderately symptomatic with HIV 
– related conditions. These include anemia, thrombocytopenia or 
nuetropenia persisting for more than 30 days; single episode of bacterial 
meningitis, pneumonia, or sepsis; CMV infection before one month of 
age; hepatitis; chronic diarrhea; lymphoid interstitial pneumonia 
(LIP);disseminated varicella zoster virus infections. Inclusion in 
category B can occur only in the absence of category C conditions. 
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4. Category C conditions, with exception of LIP,are AIDS defining 
conditions. These include, recurrent severe bacterial infections 
(meningitis, pneumonia, or sepsis), esophageal or pulmonary 
candidiasis, CMV disease at greater than one month of age, 
disseminated or extra pulmonary mycobacterium tuberculosis, 
pneumcystis carinii pneumonia, HIV encephalopathy.  
This classification system provides a useful guideline for pediatricians to 
evaluate HIV progression in children. In addition, it serves as a standard for 
researchers worldwide to measure the importance of clinical events and in drug 
trials.  
Apart from clinical manifestations the severity of illness can be assessed 
by CD4 counts in blood9. Lymphocyte counts and their subgroups depend on 
age and cut off values are different from adults. Status of immunologic 
function based on CD4 counts according to age is depicted in table below. 
 
Immunological 
categories 
Age of the child 
<12 months 1 – 5 years 6 – 12 years 
Cells / mm3  
% 
Cells / mm3     
% 
Cells / mm3  
% 
No evidence of 
suppression 
≥ 1500  
≥ 25 
≥ 1000  
≥ 25 
≥ 500  
≥ 25 
Moderate suppression 750 – 1499    
15 - 24 
500 – 999        
15 - 24 
200 – 499  
15 - 24 
Severe suppression <750          
<15 
<500            
<15 
<200         
<15 
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RECURRENT BACTERIAL INFECTIONS 10,11 
There is failure of both cell mediated and humoral immunity. Despite 
hypergammaglobulinemia, these children are at risk of severe and recurrent 
bacterial infection. There is delay in clearing of infections caused by the usual 
pathogens. Serious bacterial infections include bacteremia, meningitis, 
pneumonia, osteomyelitis, septic arthritis, and abscess at various sites. 
Bacteremia is the most common clinically diagnosed sever bacterial 
infection. In various Indian studies, up to 90% of HIV infected children had 
history of recurrent pneumonias. Initial episodes of pneumonia often occur 
before the development of significant immunosuppression. As the 
immunosuppression increases, the frequency increases. The common 
pathogens for community acquired pneumonia in these children are 
streptococcus pneumoniae, H.influenzae, staph.aureus. However children with 
severe immunosuppression and in hospital acquired infections, gram negative 
organisms, such as, pseudomonas aeruginosa gain importance. The clinical 
features of pneumonia in HIV infected children are similar to those in 
uninfected children. However, in severely immunocompromised children, signs 
may be subtle. Often, the response to therapy is slow and the relapse rates are 
high. Bacteremia may be more common, seen in upto 50 %. 
Sinusitis is the second most common clinically diagnosed bacterial 
infection in HIV infected children. A history of nasal discharge and persistent 
cough for more than 2 weeks should prompt suspicion of sinusitis in HIV 
infected children. The prevalence of meningitis, osteomyelitis, septic arthritis, 
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pericarditis and cellulitis does not appear to be unusually high. The pathogens 
and clinical symptoms are similar to immunocompetent children. 
TUBERCULOSIS 12,13 
With the spread of the HIV infection, there has been resurgence in 
tuberculosis. The two diseases have significantly detrimental interactions. Co-
existent TB and HIV infections accelerate the progression of both the diseases. 
HIV infection increases the susceptibility to primary infection, as well as to 
reactivation of tuberculosis infection due to depressed cell mediated immunity. 
Children at all stages of HIV infection can develop this infection 14,15. In turn, 
active tuberculosis accelerates the progression of HIV disease. Tuberculosis 
causes activation of cytokines like TNF. Increased elaboration of cytokines and 
increased stimulation and enhanced multiplication of lymphocyte increases 
HIV replication and plasma HIV - RNA levels16.  HIV infected children are 
more likely to have extra pulmonary and disseminated tuberculosis, the course 
is also likely to be rapid. An HIV infected child with tubercular infection is 
more likely to develop the disease than a seronegative child. The overall 
relative risk of active of active TB in children infected with  HIV  is  at  least  
5–10 fold higher than in children not infected with HIV. In the absence if 
significant immunosuppression,the clinical manifestations are not much 
different from that in seronegative children. In patients with lower CD4 counts, 
the pulmonary lesions are more extensive. Mediastinal adenopathy is also more 
frequently seen. Pleural effusions are uncommon. Diagnosis of TB in infected 
children poses greater challenge than in other children. Even with the use of a 
lower cut off of 5 mm, the tuberculin test is often negative, particularly in 
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children with immunosuppression. The incidence of MDR TB is higher in HIV 
infected children. 
MYCOBACTERIUM AVIUM – INTRACELLULARE INFECTION 
(MAI) 14 
Pulmonary disease with MAI is uncommon in children with HIV 
infection despite immunosuppression.  
The common symptoms and signs include: Persistent fever, failure to 
thrive, night sweats, lymphadenopathy, organomegaly, and refractory anemia. 
The pulmonary lesions are usually limited to lymphadenopathy and localized 
parenchymal lesions. The diagnosis of disseminated disease primarily depends 
on isolation of the organism from blood. Current therapy for disseminated MAI 
infection includes clarithromycin or azithromycin with ethambutol.  
PNEUMOCYSTIS CARINII PNEUMONIA14,17, 
PCP is the most common opportunistic infection in HIV infected 
children. However, there is lack of data from India to define the magnitude of 
the problem. The data from Africa show a low incidence of PCP. Children with 
PCP are sicker than adults with this infection with high case fatality rate. In 
1992, the estimated median survival after diagnosis of PCP was 19 months. 
Onset is acute in infants while older children have a more indolent and 
protracted course. The clinical features are tachypnoea, dyspnoea and fever. 
The examination of chest is unremarkable except for tachypnoea and chest 
retractions. Chest radiograph shows diffuse interstitial lung disease without 
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hilar adenopathy. Other patterns include localized infiltrates, hyperinflation, 
and non cardiogenic pulmonary edema. The radiograph may be normal in less 
than 5% children. Hypoxemia is the hallmark of PCP. A markedly  elevated  
(A-a) DO2 and a high serum LDH levels are often seen.  
The diagnosis of PCP begins with suspicion. The diagnosis requires 
demonstration of cysts or organisms in lung secretions or tissue. Induced 
sputum, nasopharyngeal swab, and BAL are feasible techniques to detect PCP. 
Stains like Giemsa stain (for organism), Gomori stain, toluidine blue Ostain 
(for cyst wall) are used. PCR has also been used for detecting organisms in 
respiratory secretions. 
VIRAL INFECTIONS14 
In children with AIDS, disseminated CMV is a known opportunistic 
infection, but pneumonia is rare. Prospective data showed that when HIV 
infected children develop RSV virus disease, they are less likely to wheeze and 
more likely to have pneumonia and prolonged shedding of virus. Infections 
with influenza, herpes simplex and varicella virus have been reported but are 
uncommon.  
FUNGAL INFECTIONS 14 
Fungal infections especially invasive infections are also seen more 
frequently. These include candidiasis, cryptococcosis, histoplasmosis and 
aspergillosis. Mucosal and cutaneous fungal infections are more commonly 
seen than systemic infections. Most HIV infected children develop oral 
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candidiasis at least once. These children are also at increased risk of 
oesophageal candidiasis. Pulmonary fungal infections usually present as a part 
of disseminated disease in immunocompromised children. Primary pulmonary 
fungal infections are uncommon. Pulmonary candidiasis should be suspected in 
any sick HIV infected child with lower respiratory tract infection that does not 
respond to common therapeutic modalities.  
Aspergillosis is an uncommon infection in HIV infected children. 
Invasive disease is common in these children as persistent pneumonia 
associated with atelectatic or large apical cavitatory lesions. Pneumothorax is 
common. The diagnosis of invasive bronchopulmonary aspergillosis must be 
considered in a child with compatible clinico-radiologic picture and recovery of 
organisms in pure culture from BAL, if other causes are excluded. In children 
with advanced HIV infection, the disease runs an aggressive course.  
Cryptococcosis commonly presents as a subacute meningitis or 
meningoencephalitis; many children may present with nonspecific, subtle 
symptoms, including fever and headache. Pulmonary involvement may be seen 
in half of these children. However, isolated pulmonary cryptococcosis is not 
commonly seen. Other uncommonly reported fungal infections include 
histoplasmosis and coccidioidomycosis. 
LYMPHOID INTERSTESTITIAL PNEUMONIA (LIP)18 
LIP has been recognized as a distinctive marker of pediatric HIV 
infection and is included as a Class B condition in revised CDC criteria for 
AIDS in children. While the prevalence  in  HIV infected children in the west 
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has been reported to be around 20%, figures from Africa suggest that it is not 
common. The etiology and pathogenesis of LIP are not well understood. 
Suggested etiologies include: an exaggerated immunological response to 
inhaled or circulating antigens, and/or primary infection of lung with HIV or 
Ebstein Barr virus or both. There is evidence to suggest that EBV plays 
significant pathological role in LIP.LIP is considered to reflect a local response 
to persistent antigenic stimulus that could be EBV, which is a potent polyclonal 
stimulator for B cells. 
LIP is more common in children with perinatally acquired HIV infection 
than in children who acquire HIV infection in the other ways. This may be due 
to direct intrauterine or intrapartum exposure of lung tissue to HIV. LIP is 
characterized by nodule formation and diffuse infiltration of the alveolar septae 
by lymphocytes, plasmacytoid lymphocytes,plasma cells and immunoblasts. 
There is no involvement of blood vessels or destruction of lung tissue. Children 
with LIP have a relatively good prognosis compared to other children who 
meet CDC surveillance of AIDS. LIP is usually diagnosed in children with 
perinatally acquired infection when they are older than a year of age in contrast 
to PCP diagnosed typically in the first year of life. 
The presence of reticulonodular pattern, with or without hilar 
lymphadenopathy, that persists on chest radiograph for 2 months or greater and 
that is unresponsive to antimicroboial therapy is considered presumptive 
evidence of LIP.     
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DIARRHOEA19,20 
Diarrhoea – acute,recurrent and persistent – is a common infection in 
HIV infected children. In a HIV child, infection with any enteropathogen can 
result in prolonged diarrhea and malabsorption with subsequent malnutrition. 
The etiological agents for diarrhoea include the common enteropathogens, 
C.jejuni, Helicobacter cinaedi, shigella and cryptosporidium.  
Cryptosporidium is associated with voluminous profuse watery 
diarrhea,anorexia,weight loss and even death in HIV infected individuals. Stool 
contains mucus but no blood or leucocytes. The risk of persistent diarrhea is 
increased with cryptosporidium infection. Diarrhea may also be due to 
systemic infection with atypical mycobacteria , CMV, HIV enteropathy, drugs 
or bacterial overgrowth.  
HIV ENCEPHALOPATHY 18,21 
HIV -1 associated neurological disease known as “HIV -1 associated 
progressive encephalopathy” is a common concomitant in the progression 
towards AIDS. It is characterized by a triad of symptoms including impaired 
brain growth, progressive motor dysfunction, and loss or plateau of 
developmental milestones is believed to result from both direct and indirect 
effects of HIV infection. Consequent to the hallmark systemic 
immunedeficiency of HIV infection , the CNS becomes susceptible to 
opportunistic infections, which add further morbidity and mortality and may 
contribute either directly or indirectly to neurological symptoms which can 
often mimic progressive encephalopathy. 
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Static encephalopathies represent fixed, nonprogressive neurological or 
neuro developmental deficits in HIV infected children. It may or may not be 
caused by HIV infection but are often associated with such identifiable insults 
as prematurity, in utero exposure to toxins or infectious agents or head trauma. 
ORAL MANIFESTATIONS22 
Oral manifestations are directly related to degree of immunosuppression 
and such lesions can be considered as indicators of the progression of HIV 
infection in children. 
Santosh L.C et al,involving 80 HIV infected children ( average age of 
6.3 ± 3.2years) , 30 ( 38 %) had some type of oral lesions; the CD4 counts were 
lower than that found in lesion free children. Common lesions include 
candidiasis ( 22.5 %) ,gingivitis ( 17.5 %) , enlargement of parotids ( 8.8 %) , 
herpes simplex ( 1.3 %), and hairy leukoplakia ( 1.3 %)  
HEMATOLOGICAL MANIFESTATIONS 18 
Hematological manifestations in pediatric HIV infection include anemia, 
neutropenia, absolute or relative lymphopenia, thrombocytopenia and 
eosinophilia. Severe thrombocytopenia and anemia are correlated with poor 
prognosis. These abnormalities may occur because of peripheral destruction of 
blood elements, HIV replication, poor nutritional status and adverse effects of 
medications. 
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CARDIOMYOPATHY 24 
Cardiovascular problems associated with infection including left 
ventricular dysfunction and increased left ventricular mass are common and 
clinically important indicators of survival for children infected with HIV. A 
prospective multicenter cohort study has evaluated 205 vertically HIV – 
infected children enrolled at a median age of 1.9 years, 600 HIV – exposed 
children enrolled prenatally or as neonates, of whom 93 were ultimately HIV – 
infected. The main outcome measures were echocardiographic indices of left 
ventricular dysfunction. Left ventricular dilatation, heart failure, and / or the 
use of cardiac medications were more common in infected compared with 
uninfected children. The mortality rate 1 year after the diagnosis of heart 
failure was 52.5% (95% CI, 30.5 – 74.5). Authors concluded that cardiac 
dysfunction occurred in 18% to 39% of HIV – infected children and was 
associated with an increased risk of death. They have recommended that HIV – 
infected children should undergo routine echocardiographic surveillance for 
cardiac abnormalities. Zidovudine induced cardiomyopathy has also been 
reported. 
RHEUMATOLOGICAL MANIFESTATIONS23  
Rheumatological manifestations are uncommon in HIV–infected 
children. In one study 23, these were identified in 5 (19.2 %) out of 26 children. 
These included biphasic Reynaud’s syndrome,necrotizing vasculitis, lip 
necrosis, livedi reticularis, knee arthralgia, vasculitis, and septic arthritis of 
ankle. All of the rheumatological manifestations were seen in advanced stage 
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of HIV disease. These rheumatological changes were similar to those reported 
for HIV- positive adults. 
OTHER MANIFESTATIONS 14,18 
HIV – infected children also suffer from various infectious and non-
infectious conditions of the skin. Non infectious conditions include seborrhoeic 
dermatitis, atopic dermatitis, eczema, drug eruptions and skin lesions 
associated with nutritional deficiencies. Up to 10% of HIV-infected children 
may have nephropathy. This may manifest with hematuria, proteinuria, renal 
tubular acidosis, and acute renal failure. These manifestations are common with 
advanced disease. Majority of HIV – infected children suffer from nutritional 
and growth abnormalities.  
Growth retardation in HIV infected infants is evident as early as 4 – 6 
months of age. HIV infection or associated opportunistic growth first affects 
linear growth. Overall effect on height for age is more than weight for age. 
Early growth delay has been correlated with viral load.  In addition, recurrent 
infections, decreased oral intake because of oral and esophageal lesions and 
various organ dysfunctions also contribute to failure to thrive.  
Hepatomegaly is the common clinical manifestation of pediatric HIV 
disease. Histopathological findings in liver include: fatty infiltration of 
hepatocytes, portal inflammation, CMV inclusion bodies and giant cell 
transformation and chronic active hepatitis characterized by lymphocytic 
infiltration in portal spaces and lobules.  
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Lymphadenopathy is seen in infants and children with HIV. Generalized 
lymphadenopathy may be because of HIV infection, other viral infections 
(Ebstein Barr virus or CMV), opportunistic infections and malignancies 
(lymphoma / leukemia). 
The prevalence of malignancies in HIV infected children is believed to 
be significantly higher than in normal population. The common malignancies  
reported in HIV infected children include: non Hodgkin’s lymphoma, 
leiomyosarcoma or leiomyoma, leukemia, kaposi’s sarcoma, Hodgkin’s 
lymphoma, vaginal carcinoma in situ and tracheal neuroendocrine carcinoma. 
CLINICAL CASE DEFINITION OF HIV INFECTION 
Since majority of infections are acquired vertically, the best method for 
identification of HIV infection should be to screen all mothers and suspect HIV 
in babies born to HIV positive mothers. Since screening of mothers for HIV is 
not done universally and some patients get HIV infection through transfusion 
of blood and blood products, we may see children with clinical manifestations 
of HIV in majority. 
Because of the limited availability of HIV diagnostic testing, attempts 
have been made to formulate clinical AIDS definitions for adults and children 
in developing countries. Use of the Centre for Disease Control and Prevention 
(CDC) guidelines for clinical classification of HIV infection in children is 
problematic because they were designed to measure HIV disease progression, 
not for the identification of children infected with HIV. In addition, many 
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category C (or AIDS) diagnoses are beyond the diagnostic capabilities of most 
of the developing world.  
Several simple clinical case definitions pertinent to the developing world 
have been devised and tested, including the WHO clinical case definition25. 
These definitions detect the presence of symptomatic AIDS and not HIV 
infection itself and are confounded by prevalent conditions such as 
malnutrition, diarrhoeal disease and tuberculosis. There are no published 
studies in literature to test the sensitivity and specificity of WHO’s modified 
criteria in Indian patients. The reported26,27 sensitivity of individual factors 
including weight loss or failure to thrive is 45–100%, chronic diarrhea  (>1 
month)  15 – 45 %, and severe or repeated pneumonia 8 – 86%. For minor 
criteria such as generalized lymphadenopathy is 23 – 41% and for oro-
pharyngeal candidiasis 14 – 48%. The wide variations in sensitivity is due to 
different clinical settings. The published studies do not mention about the 
sensitivity of two major signs associated with at least two minor signs. 
One should suspect HIV infection in a child who presents with 
symptoms described in category C of CDC, has specific illness like LIP, has 
atypical manifestations of common illnesses, presents with combinations of 
symptoms or born to HIV positive parents. 
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CLINICAL CASE DEFINITIONS OF PEDIATRIC AIDS 
Modified WHO Criteria for case definition for pediatric AIDS 
Major criteria    Minor criteria 
Weight loss or failure to thrive  Generalized lymphadenopathy 
Chronic diarrhea (> 1 month)   Oropharyngeal candidiasis 
Prolonged fever  (> 1 month)   Repeated common infections 
Severe or repeated pneumonia 
Generalized dermatitis 
Confirmed maternal infection 
Pediatric AIDS is suspected in an infant or child presenting with at least 
two major signs associated with at least two minor signs in the absence of 
known causes of immunosuppression.  
STRATEGIES OF HIV TESTING 28 
Various categories of tests are used in combinations 
i. ELISA / Simple / Rapid /, Elisa / Rapid / Simple used in category 
I,II 
ii. Supplemental tests like Western Blot, Line immunoassay are 
used in problem cases or when results are indeterminate. 
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Strategy I 
Serum is subjected to one E / R/ S for HIV. If negative, it is to be 
considered free of HIV and if positive the sample is taken as positive. This 
method is used for ensuring donation safety. 
Strategy II 
A serum is considered negative if the first ELISA is negative. If reactive 
it is subjected to a second ELISA which utilizes a different system from the 
first one. It is reported reactive only if the second test confirms the results of 
the first. This strategy is used for surveillance and diagnosis only if some 
indicator of the disease is present. 
Strategy III 
It is similar to the above strategy II with the addition of a third reactive 
ELISA being required for a sample to be considered as positive. The test for 
the first ELISA should have high sensitivity and for the second and third 
ELISA high specificity. It is used to diagnose infection in asymptomatic 
individuals.                     
Testing for HIV infection involves aspects of pretest counselling, 
explicit consent and confidentiality. Laboratory safety must be strictly followed 
according to Good Laboratory Practice( GLP) guidelines and universal 
precautions must be observed. 
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Types of tests available are 
1. Anti HIV antibody tests,  
2. Virus based tests,  
3. Immunological tests and  
4. Surrogate markers. 
Specimens used to test for HIV infection 
1. Antibody detection: blood, serum / plasma. 
2. Antigen detection: serum / plasma, CSF, Cell culture 
supernatant 
3. Virus isolation and detection of viral nucleic acids:  
Plasma, semen, vaginal / cervical specimens, CSF. 
Less successful – saliva, urine, breast milk, tears and amniotic fluid. 
Anti HIV antibody tests: 
There are two categories:  
1. Screening tests    
2. Supplemental tests 
I. SCREENING TESTS 
a. Conventional micro well ELISA tests  
b.  Rapid tests 
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Screening tests employed should test antibodies to both HIV 1 and HIV 
2 and their subtypes including O and N. 
b. ELISA ( Enzyme linked immunosorbent assay) 
This is the most commonly performed test to detect HIV antibodies. 
Types of ELISA based on the principle 
1. Indirect ELISA 
2. Direct ELISA 
3 Competitive ELISA 
4. Antigen sandwich and  
5. Antigen antibody capture assay. 
Types of ELISA based on antigen utilized 
1. First - infected cell lysate 
2. Second - recombinant glycoprotein 
3. Third - synthetic peptidase   
ELISA can take up to 3 hrs to yield results. 
a. Rapid tests 
They give results within minutes (3 – 30 minutes). Various rapid 
tests available are –  
1. Dot blot assays 
2. Particle agglutination ( gelatin, RBC, latex, micro beads)   
3. HIV spot and Coomb’s tests 
4. Fluorometric microparticle technologies 
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i. Supplemental Tests 
These tests are used if the results of the screening tests are discordant 
and for research purposes. Otherwise according to the WHO guidelines, an 
individual reactive to three different systems of ELISA or rapid tests can be 
labeled to be having HIV infection.     
These tests also identify and differentiate infections by HIV - 1 and 
HIV– 2.             
These tests include – 
Western Blot (WB), Line immunoassay (LIA), Recombinant 
Immunoblotting assay (RIBA) 
Western Blot analysis is done by electrophoresis if plasma on a pre – 
impregnated strip containing various antigens of HIV. WB is interpreted as 
positive if at least 2 or 3 bands (p 24, gp 41, gp 120/160) are positive. 
Direct detection of HIV 
Direct detection of virus would be needed in the following settings –  
For diagnosis 
HIV infection in the newborn, Indeterminate WB / LIA / RIBA results, 
Monitor viral load during antiretroviral therapy, HIV infection status during 
window period, Detection of site specific infection                                                                       
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For research 
Subtyping of HIV 
Cloning genes for diagnosi\tic kits / vaccines,Generating chimeric virus 
Techniques  used: 
1. Detection of p24 antigen 
2. Culture isolates of HIV 
3. Detection of HIV specific DNA or RNA Polymerase Chain 
Reaction ( PCR) 
HIV p24 core antigen 
HIV p24 antigen is detected and quantified using EIA. Specificity and 
sensitivity reported are 79 % and 99% respectively. It correlates well with the 
disease progression. P24 is undetectable in most asymptomatic patients and 
infants. It also shows poor intrasample reproducibility. All these factors limit 
the utility of p24 assay. 
Immune complex dissociated ( ICD ) p24 antigen 
p24 antigen dissociated from the immune complexes improves the 
sensitivity of the assay. However, the sensitivity level is sub optimal for early 
diagnosis of HIV infection. 
HIV isolation by viral culture 
This requires at least P 2+ containment facility and high degree of 
expertise. Autologous or heterologous peripheral blood mononuclear cells 
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(PBMCs) activated with mitogen are co cultured with infectious material at 
37ºC in  5% CO2 for about 28 days. The presence of the virus is detected by 
presence of p24 antigen or reverse transcriptase enzyme in the culture 
supernatant. This method has the sensitivity and specificity of PCR, however it 
is costly, labor intensive and takes 2 to 4 weeks. 
Polymerase chain reaction (PCR) for HIV 
HIV DNA PCR (Qualitative) 
This detects proviral DNA that is integrated with the host cell. This is 
best done using Reverse Transcriptase (RT) PCR. Because of the high 
sensitivity of the test, care is taken to avoid cross contamination of samples or 
carry over of amplified products. 
HIV RNA PCR (Quantitative) 
This is done using RT PCR or nucleic acid sequence based amplification 
(NASBA) and branched chain DNA (bDNA) techniques. Comparative analyses 
have shown that quantitative PCR studies are more sensitive measures of viral 
load than p24 assays and culture techniques at all stages of HIV infection, 
enabling detection of virus in plasma even when other assays are negative. 
Laboratory diagnosis of HIV infection in the newborn (congenital 
infection) 
The risk of mother to child transmission of HIV is 25 – 45%. Maternal 
IgG to HIV crosses the placenta and persists for 6 – 18 months. It is essential to 
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diagnose infections in newborns as early as possible. It relieves the parents’ 
anxiety and is helpful to consider antiretroviral therapy in infected babies. PCP 
prophylaxis can be stopped if the baby is not infected. Early diagnosis also 
helps timely decisions regarding breast feeding, immunization etc. Distinction 
between maternal and neonatal IgG is difficult. The following tests can be used 
for early detection of congenital HIV infection: 
1. Detection of Ig A and or Ig M anti HIV antibodies: Ig A 
antibodies appear at 3 – 4 months of age and Ig M by six months 
of age. Ig A after 3 months of age has a sensitivity of 97.6% and 
specificity of 99.7%. Ig M production is erratic and elicits false 
positive results.   
2. Estimation of p24 antigens: this has high frequency of false 
positivity in the first month of life. 
3. HIV DNA PCR, HIV RNA PCR and viral cultures: PCR is 
preferred over culture techniques. It invariably has a specificity 
of > 95%. The sensitivity ranges from 38% within 48 hrs of  
birth, to more than 93% at 14 days and 96% by 28 days of life. 
Cord blood is not to be used for testing as there can be contamination. 
The negative ELISA done between 6 – 18 months in the absence of clinical 
disease will rule out HIV infection ( in an infant who is not breast fed ). 
For infection in utero, the HIV DNA PCR or viral culture has to be 
positive in the first 48 hours.  For intrapartum infection the tests within 48 
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hours are negative but positive after one week. If one PCR is to be done due t 
cost constraints then it is best performed between 3 to 6 months of age. 
Reporting procedure 
The results are kept confidential. 
Negative – if the initial / screening test is nonreactive. 
Positive – if the sample shows reactive results by three screening tests. 
Indeterminate – if the sample shows discordant results by three 
screening tests. Confirmatory assay is to be done. If the confirmatory assay is 
indeterminate the following samples are tested at three, six and 12 months 
before the result is reported. If still indeterminate after one year, the person is 
declared negative. 
In summary, to diagnose congenital HIV infection in early infancy 
ELISA is unreliable. The mainstay is by HIV PCR or rarely by viral culture. 
After 18 months of age three serial ELISAs can be done. The disease progress 
has to be monitored by assay of CD4 counts.  
GENERAL MANAGEMENT OF HIV IN CHILDREN 29 
Early management of pediatric HIV disease is based on timely 
institution of chemoprophylaxis, immunization, management of opportunistic 
infections, nutritional support and anti retroviral therapy. However early 
management using appropriate measures are possible only if these children are 
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diagnosed early. Spectacular advancement has been made in strategies to 
reduce mother to child transmission. The vertical transmission of HIV infection 
may occur in utero (30 – 50%), intrapartum (50 – 70%), or through breast 
feeding (about 15%). Of the HIV infected children about 20 – 30% are rapid 
progressors. Among the slow progressors 15% are asymptomatic even at 5 
years of age. The slow progressors reveal a lower rate of fall of absolute 
CD4counts. The median survival time of vertically infected children is reported 
to be 8 – 9 years. Plasma HIV RNA levels of more than 2, 99,000 copies per 
milliliter in an infant has been correlated with rapid progression of the disease 
and death. In general, plasma HIV RNA levels of more than 1,00,000 copies  / 
ml and CD4 counts of < 15 % are considered as poor signs of survival. 
Breast feeding 
There is 14 – 16 % risk of mother to child transmission of HIV through 
breast milk. In a developing country like India where the breast feeding 
safeguards against risk for diarrhea and respiratory infections, which by 
themselves are associated with high mortality and morbidity, the risks from 
breastfeeding needs to be individualized. Whenever safe, cost effective and 
alternate source of milk are available, the HIV infected mother need to be 
counselled not to breast feed their infants. Mother and family participation in 
decision making is imperative. 
Nutrition 
Factors like repeated infections, poor intake, malabsorption, increased 
requirements and emotional deprivation make a HIV positive child more prone 
for malnutrition. Malnutrition itself can augment the immunodeficiency in HIV 
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infected children. The diet should consist of high calories, proteins and 
vitamins preferably from home made foods. Treatment of opportunistic 
infections, oropharyngeal and esophageal candidiasis, diarrhea and respiratory 
infections is necessary to help in keeping the oral intake adequate. Health 
education and economic support may be necessary for better nutrition. In 
extreme or terminal cases tube feeding or total parenteral therapy may become 
necessary for a short period of time. Emotional and psychological support for 
the family is essential. 
Anti retroviral therapy  
Three classes of anti retroviral therapies (ART) are available for HIV. 
Two of these target the reverse transcriptase enzyme,  nucleoside (NRTI) and  
non-nucleoside (NNRTI)  reverse transcriptase inhibitors. The third class of 
drug is a protease inhibitor which target the viral protease enzyme. Drug 
absorption, metabolism, pharmacokinetics and interactions should be 
understood well before undertaking therapy. Compliance is also difficult as the 
drugs are expensive and some are unpalatable. Treatment with ART needs 
proper patient selection, appropriate choice of drugs, monitoring and evaluation 
to look for need of change in treatment regimens. 
Management of opportunistic infection 
Prior to the use of ART in survival of HIV infected children were 
mainly due to chemoprophylaxis of opportunistic infections. Pneumocystis 
carinii pneumonia (PCP) is the most common infection seen in about a third of 
pediatric HIV infected patients and is an important clinical indicator of AIDS. 
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PCP prophylaxis is done using Trimethoprim – Sulphamethoxazole (TMP – 
SMX). Fungal infections are common in HIV / AIDS children. Oral or topical 
drugs are used in early cases and intravenous anti fungal agents in non-
responders and in wide spread disease. Cryptococcal meningitis, CMV retinitis, 
varicella zoster, herpes simplex virus infection and measles are uncommon in 
children. 
Monitoring growth and development 
Anthropometric measurements at regular intervals are necessary for 
early recognition of growth failure and malnutrition. Height, weight, head 
circumference and skin fold thickness measurements can be used to predict 
disease progression and overall effectiveness of  ART. Mental development 
should be monitored as it can be affected due to encephalopathy and 
opportunistic infections. 
Counseling 
Counseling to the patient and the family members should be an essential 
ongoing process throughout the course of the disease. The mother or the care 
giver should be counseled regarding diagnosis, treatment, follow up, 
prophylaxis against opportunistic infections, immunization, breastfeeding, 
prevention of transmission of HIV and socio-economic consequences of the 
infection.   
Schooling 
Children with HIV infection should not be excluded from school for the 
protection of other children and personnel since HIV does not spread through 
 32
the types of contact that may occur in school. The family of an affected child 
has the right, but not obliged to inform the school about the infection status of 
the child. All schools should adopt the standard procedures for handling blood 
or contaminated fluids regardless of the HIV status.  
Home care 
The family should follow standard guidelines to prevent exposure to 
HIV infected material. Sharing of toothbrushes, razors should be avoided. 
Hands and body parts should be readily washed after contact with blood. 
Routine changing of diapers and nose wipes should be followed by hand 
washing. 
When blood or  blood-contaminated fluids are spilled the surface should 
be cleaned and then disinfected with freshly prepared 1 :10 dilution household 
bleach. 
Immunization   
Immunization in the HIV positive chidlren differs from the routine as 
live vaccines are contraindicated with some exceptions. There may be a sub-
optimal sero conversion after vaccination. 
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RECOMMENDATION FOR VACCINATION IN DEVELOPING 
COUNTRIES 
 
VACCINE RECOMMENDATION 
BCG Recommended by WHO, as tuberculosis is rampant and 
neonates are asymptomatic. 
OPV Ideally IPV should be given. Since it is not available 
OPV is recommended, as evidenced by absence of 
complications in those who were given OPV in early 
epidemics.  
Measles,   MMR Measles and MMR vaccines are contraindicated only in 
children who are severely immunocompromised. 
(category C) 
DPT,Hepatitis 
B,Hemophilus 
influenza type B 
These vaccines are recommended because they do not 
contain any live agent. Hepatitis B immunoglobulin 
should be given within 7 days of exposure. 
Varicella Recommended only for the asymptomatic or mildly 
symptomatic (CDC classification N1 or A1 with an age 
specific CD4 of >25%). Immunoglobulin should be 
given within 4 days of exposure. 
Pneumococcal All HIV infected children who are 2 years or older 
should receive the vaccine, with a booster 5 years later. 
Influenza HIV positive children should receive yearly vaccine 
after 6 months of age. 
Hepatitis A Recommended for those living in endemic areas. 
Typhoid Vi polysaccharide vaccine is recommended. Oral 
typhoid vaccine is contraindicated. 
Rabies Vaccine and immunoglobulin can be given for post 
exposure prophylaxis. 
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AIM OF THE STUDY 
To find the probability that child is sero positive for HIV when the child 
is admitted with at least one of the selected manifestations 
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MATERIALS AND METHODS 
Type of study  : Prospective study 
Place of study  : Institute of Social Pediatrics, 
                                             Stanley Medical College & Hospitals. 
 
Duration of study  : December 2005 to May 2007.  
Inclusion criteria :  Any children who are admitted with any of  
the selected manifestations 
 
Exclusion criteria  : Any children who are already seropositive  
for  HIV 
 
Children aged 0 – 12 years admitted in Institute of Social Pediatrics, 
Stanley Medical College & Hospitals, were taken and among them who had 
any of the selected  clinical manifestations suggestive of HIV were chosen as 
subjects. HIV serology was done after pre-test and post-test counseling (done 
by ICTC Counselors) and informed consent from them by ELISA method and 
for children below 18 months as the ELISA is not confirmatory they are 
subjected to detect HIV DNA if they are ELISA positive. 
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DEFINITION OF CLINICAL RISK FACTORS STUDIED 
1.  FEVER FOR MORE THAN A MONTH:  
Documented fever (axillary temperature more than  37.8 ºC) over a month 
2. CHRONIC DIARRHOEA 
Presence of two or more loose stools per day for a period exceeding one 
month. 
3. SEVERE MALNUTRITION 
The presence of grade III protein energy malnutrition as defined by 
Gomez’s classification, namely 60% or less of expected weight  for the age 
using the fiftieth percentile of the NCHS standards as the reference 
4. PERSISTANT PNEUMONIA 
History of cough for more than one month 
5. GENERALISED LYMPHADENOPATHY 
Presence of enlarged lymph nodes(diameter of lymph nodes more than  
1 cm in axilla and cervical region and more than 1.5 cm in inguinal region) in 
two or more non contiguous sites for more than 3 months. 
6. ORAL THRUSH 
Presence of whitish plaques in the oral cavity which could not be easily 
removed and when removed showed an erythematous base. 
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7. HEPATO SPLEENOMEGALY 
Liver span more than 4 – 7 cm ( depending upon patient’s age) as 
detected clinically,moderate splenomegaly 
8. REPEATED COMMON INFECTION 
Two or more episodes of infections such as upper respiratory tract 
infections and gastroenteritis in the last 6 months. 
9. GENERALISED DERMATITIS 
Which includes eczema,disseminated maculopapular dermatoses. 
10. CHRONIC PAROTID SWELLING 
Swelling of at least one of the parotid glands for a minimum period of 3 
months. 
11. RECURRENT BACTERIAL INFECTIONS 
Occurrence of more than two episodes of serious bacterial infections 
such as pyogenic meningitis and pneumonia in two years period.   
Pyogenic meningitis. Diagnosed on the basis of clinical history , signs of 
meningeal irritation and results of CSF examination   
Pneumonia: Diagnosed on the basis of clinical findings and results of 
radiological studies. 
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12. DISSEMINATED TUBERCULOSIS 
Milliary tuberculosis {diagnosed on the basis of milliary mottling on 
the chest radiograph} or CNS tuberculosis: {diagnosed on the basis of CSF 
findings and / or results of neuroimaging studies in relevant clinical settings} or  
Pulmonary tuberculosis in conjugation with abdominal tuberculosis 
{diagnosed on the basis of results of radiological, bacteriological and 
cytological studies in clinically relevant settings} 
13. PNEUMOCYSTIS CARINII PNEUMONIA 
Diagnosed on the basis of clinical features{fever,cough,respiratory 
distress}, results of arterial blood gas analysis, findings on chest radiograph and 
microbiological studies.  
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OBSERVATION AND RESULTS 
AGE AT PRESENTATION: (in months) 
Mean 45.43 
Std deviation 36.776 
Minimum 3 
Maximum 144 
 
 Frequency Percent 
<1.5 yrs 43 33.6% 
1.5 -5 yrs 49 38.3% 
>5 yrs 36 28.1% 
 
Age 
ELISA Status 
Negative Positive 
n Row % n Row % 
1.5 yrs 39 90.7 4 9.3% 
1.5-5yrs 43 87.8 6 12.2% 
>5yrs 34 94.4 2 5.6% 
X2 = 1.09, p =0.58, not significant 
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In this study mean age at presentation of children with clinical 
manifestations was 45.4 months with maximum of 144 months and minimum 
of 3 months 
Of 128 children included in our study, 33.6%(43) were <1.5 yrs, 
38.3%(49)  were 1.5-5 yrs , 28.1%(36)  were >5 yrs. 
SEX 
Of 128 children 77 were male and 51 were female 
Sex ELISA  Status Total 
Negative Positive 
Male 70 7 77 
Female 46 5 51 
X2=1.09,p=0.89 not significant 
Of 77 male children 7 were positive for elisa and of 51 female children 5 
were positive for ELISA. There was no significant correlation between sex and 
seropositivity 
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OCCUPATION OF PARENTS  
Mother’s occupation 
Among then128 children enrolled in the study 109 children’s mothers 
were house wife 19 were working women  all the mothers of children who 
were positive were housewife  this was statistically significant 
Mother 
Elisa status 
Total 
Negative Positive 
  House wife 97 12 109 
 Working women 19 0 19 
X2=6.46, p =0.03 significant 
Father’s occupation 
Among the fathers of children in the study 84 were daily wagers by 
occupation followed and masons, fishermen and tailors. Others were less in 
number. 
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Father’s 
occupation 
Elisa status 
Total 
Negative Positive 
Auto driver 1 0 1 
Barber 1 0 1 
Carpenter 1 0 1 
Cooley 76 8 84 
Farmer 3 1 4 
Fisherman 5 0 5 
Lorry driver 0 1 1 
Mason 9 2 11 
Painter 2 0 2 
Rickshaw man 3 0 3 
Salesman 1 0 1 
Shop owner 2 0 2 
Steel  polisher 5 0 5 
Tailor 6 0 6 
Tea vendor 1 0 1 
Total 116 12 128 
 
We could not find any correlation between father’s occupation and elisa 
positivity in children. 
Elisa status of parents 
HIV status of father was not known in 125 children and was positive in 
3 children all the children who were positive were among children whose 
father’s elisa status was not known 
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HIV status 
of father 
Elisa  status Chi square 
Negative Positive X2=0.32 
p=0.57 not 
significant 
n % n % 
No 113 97.4% 12 100% 
Yes 3 2.6%   
 
There was no correlation between father’s ELISA status and HIV 
positivity in children 
HIV status of mother was not known in 123 children and was positive in 
5 children and all the children who were positive were among the 123. 
HIV status 
of mother 
Elisa status Chi square 
Negative Positive  
X2=0.53 
p=0.46 not 
significant 
n % n % 
No 111 95.7% 12 100% 
Yes 5 4.3%   
 
History of previous blood transfusion 
In this study history of previous blood transfusion was negative in 126 
children was positive in two One among the two was positive and it was 
statistically significant 
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H/O previous 
blood 
transfusion 
Elisa status Chi square 
Negative Positive  
X2=3.95 
p=0.05 
significant 
n % n % 
       No 115 99.1% 11 91.7% 
       Yes 1 0.9% 1 8.3% 
 
Risk factors for HIV 
Among the selected manifestations suggestive of  HIV in children oral 
thrush,generalized lymphadenopathy and wasting were significant risk factors 
for child being HIV positive in this study. Among 128 children 89 had no 
wasting and 39 had wasting and among the 89 who had no wasting 5 were 
positive and of 39 with wasting 7 were positive. This was statistically 
significant. 
Wasting 
Elisa status Chi square 
Negative Positive 
X2=4.85 
p=0.02 
Significant 
n % n % 
No 84 72.4% 5 41.7% 
Yes 32 27.6% 7 58.3% 
 
Among 128 children in the study 122 had no oral thrush and 6 had oral 
thrush among 122 who had no thrush 9 were positive and among 6 with oral 
thrush 3 were positive. This was statistically significant. 
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Oral 
thrush 
Elisa status Chi square 
Negative Positive  
X2=12.2 
p=0.001 
significant 
n % n % 
No 113 97.4% 9 75% 
Yes 3 2.6% 3 25% 
 
 Among 128 children 107 had no generalised lymphadenopathy and 21 
had generalised lymphadenopathy. Among 107, 7 were positive and among 21 
5 were positive. This was statistically significant. 
GLA 
Elisa status Chi square
Negative Positive  
X2=6.16 
p=0.001 
significant 
n % n % 
No 100 86.2% 7 58.3% 
Yes 16 13.8% 5 41.7% 
 
Taking in to account oral thrush and wasting as one group among 128 
children 84 had neither oral thrush nor wasting and 44 had either wasting or 
oral thrush and sensitivity and specificity both increased when both were taken 
as one group 
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Oral 
thrush 
and 
wasting 
Elisa status Chi square 
Negative Positive  
X2=6.12 
p=0.01 
significant 
n % n % 
No 80 95.2% 4 4.8% 
Yes 36 81.8% 8 18.2% 
 
This prospective study enrolled 128 children(77 boys; 51 girls m:f 3:2) 
aged 0-12 yrs mean age of study population was 45.43 ± 36.776 months 
maximum number of children were in the age group of 1.5-5yrs (49,38.3%). 
Wasting was the commonest sign noted in the children enrolled (39, 30.5%) 
followed by hepatosplenomegaly (32, 25.2%). 
None of the children had LIP, Esophageal candidiasis, PCP, HIV 
encephalopathy. Provisional diagnosis at the time of admission were TB, 
Pnuemonia, Acute Gastro Enteritis , probable immunodeficiency, typhoid, 
malaria, leukemia, lymphoma, PEM, etc. 
RELATIONSHIP BETWEEN RISK FACTOR AND HIV POSITIVITY 
In study population 12 children were found to be positive (9.3%). 
Seropositivity rate of various manifestations varied from 8.3 % for 
persistent pneumonia, 16.7 % for Hepatosplenomegaly, 25 % for oral thrush, 
41.7 % for GLA and 58.3 % for wasting.  As noted , oral thrush, wasting and 
generalized lymph adenopathy were significant clinical risk factors for 
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predicting HIV seroprevalence.Children with oral thrush had 17 times 
increased risk of being HIV positive compared to those who did not have 
thrush. Children with wasting have 3 times increased risk of being HIV 
positive compared to those who did not have wasting. Though 
hepatosplenomegaly was not a significant risk factor for HIV seropositivity 
,Children with hepatosplenomegaly have 2 times greater risk of being 
seropositive than those without hepatosplenomegaly. Though generalized 
lymphadenopathy was  a significant risk factor for HIV seropositivity ,Children 
with generalized lymphadenopathy have 2 times greater risk of being 
seropositive than those without generalized lymphadenopathy.Though 
lymphoma was not a significant risk factor for HIV seropositivity ,Children 
with lymphoma have 3 times greater risk of being seropositive than those 
without lymphoma. 
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Manifestations 
ELISA STATUS 
Chi square test Negative Positive 
n % n % 
Previous BT 
  
No 115 99.1% 11 91.7% χ2=3.95 P=0.05 
Significant Yes 1 0.9% 1 8.3% 
GLA 
  
No 100 86.2% 7 58.3% χ2=6.16 P=0.001 
 Significant Yes 16 13.8% 5 41.7% 
HSM 
  
No 85 73.9% 10 83.3% χ2=0.51P=0.47 
not significant Yes 30 26.1% 2 16.7% 
Persistant 
pnuemonia  
No 97 83.6% 11 91.7% χ2=0.53 P=0.46 
not significant Yes 19 16.4% 1 8.3% 
Multiple 
bacterial 
infection 
No 99 91.4% 12 100.0% χ2=1.12 P=0.28 
not significant Yes 17 8.6%   
Disseminated 
TB  
No 105 91.3% 10 83.3% χ2=0.81 P=0.37 
not significant Yes 10 8.7% 2 16.7% 
Prolonged  fever 
  
No 100 87.0% 12 100.0% χ2=1.77 P=0.18 
not significant Yes 15 13.0%   
Chronic cough 
  
No 114 98.3% 12 100.0% χ2=0.21 P=0.65 
not significant Yes 2 1.7%   
Chronic 
diarrhea  
No 112 98.3% 12 100.0% χ2=0.21 P=0.65 
not significant Yes 4 1.7%   
Wasting 
  
No 84 72.4% 5 41.7% χ2=4.85 P=0.02 
Significant Yes 32 27.6% 7 58.3% 
Oral thrush 
  
No 113 97.4% 9 75.0% χ2=12.2 P=0.001 
 significant Yes 3 2.6% 3 25.0% 
Generalized 
dermatitis  
No 113 98.3% 12 100.0% χ2=0.21 P=0.65 
not significant Yes 2 1.7%   
Recurrent 
common 
infection  
No 108 93.1% 12 100.0% χ2=0.88 P=0.64 
not significant Yes 8 6.9%   
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DISCUSSION 
HIV infection has become one of the greatest pandemic ever. Children 
are caught in the HIV epidemic as innocent by standers It is in the process of 
nullifying all the good works and achievements done in the field of child 
survival in the form of immunization, ARI control programme, Diarrhoea 
control programme, promotion of breast feeding. This determines a major set 
back to child health. 
One of the problems in establishing the diagnosis in developing 
countries has been the lack of adequate lab facilities and fact that clinical 
manifestations of HIV infection in children are often seen in uninfected 
children30. There are few published reports of clinical manifestations in 
pediatric HIV infection in India.  
At the same time undertaking workup for the diagnosis of HIV infection 
means spending of community’s precious resources31. Although antibody based 
tests for diagnosis are comparitively inexpensive, the cost involved in 
associated process of counseling can be enormous. Counselling is also 
considered to be time consuming and is emotionally draining on the staff32.              
Routine HIV testing is not a feasible option considering the economical 
and psychological cost involved. Clinically directed selective screening is the 
only way out to achieve the dual objective of diagnosing the maximum number 
of subjects without  wasting resources in undue manner.  
In our study, the overall seropositivity  rate was 9.3 %. This rate cannot 
be considered to reflect seropositivity rate in population not even in children. It 
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could be much lower. The rate found in this study indicates that selectively 
directed screening has been abled to facilitate diagnosis of HIV infection in 
hospitalized children. 
We selected several risk factors that included common clinical features 
seen in admitted children (prolonged fever, severe malnutrition, persistent 
cough, repeated common infection, generalized lymphadenopathy and 
hepatosplenomegaly), features that were considered highly specific for 
childhood HIV infection (Pnuemocystis Carnii Pnuemonia, chronic parotid 
swelling, recurrent bacterial infection) and features reported to be associated 
with higher seropositivity rate for HIV infection (chronic diarrhea, oral 
candidiasis, disseminated TB). 
This study could not encounter single case of PCP, LIP, HIV 
encephalopathy. This indicates these signs are uncommon in admitted children 
whether HIV positive or otherwise.   
AGE AT PRESENTATION 
 
Study Mean age at presentation 
S.Bavadekar etal (2005)31
Daniel E.Alikor et al., (2006)33 
Tahziba Hussain et al., (2004)34 
R.Lodha et al., (1999)3 
R.Dhurrat et al., (2000)26 
R.Merchant et al ., (1997)27 
This study.  
55 months 
84 months 
42 months  
55 months 
38 months 
38 months 
45 months 
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In this study, mean age at presentation was 45 months which is close to 
that of study by Tahziba Hussain et al34. which showed 42 months as mean age 
at presentation, while others like R.Lodha et al.3, Daniel E.Alikor et al33.and 
S.Bavadekar et al31 showed higher age at presentation and R.Dhurrat et al26 and 
R.Merchant et al 27., showed lower age at presentation. This may be due to 
varied age at presentation in different communities. The study could not find 
any correlation between seropositivity for HIV and age at presentation. 
However the selected manifestations were 56% sensitive and 58% specific 
between age groups of 31 to 34 months in this study.  
SEX 
Study  Significance 
Tahziba Hussain et al., 
(2004)34 
 
S.Bavadekar etal (2005)31 
 
R.Dhurrat et al., (2000)26 
 
Daniel E.Alikor et al., 
(2006)33 
 
This study 
Significantly higher in males than females 
 
 
No significant statistical difference between 
gender 
 
No significant statistical difference between 
gender 
 
No significant statistical difference between 
gender 
 
No significant statistical difference between 
gender 
 
The study showed no significant statistical difference in seroprevalence 
for HIV between gender. This was supported by studies like S.Bavadekar etal 
(2005)31,R.Dhurrat et al., (2000)26,Daniel E.Alikor et al., (2006)33 while 
Tahziba Hussain et al., (2004)34 found HIV infection was significantly higher 
in male children (82%) than female children (18%) when found along with TB. 
This may be due to higher prevalence of TB in males.  
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PARENT OCCUPATION 
FATHER’S OCCUPATION 
This study could not find any correlation between father’s occupation 
and ELISA positivity in children. Most of the fathers were laborer by 
occupation (84, 65%) followed by mason (11, 8%).  
Rodriquer B and Steil Duncan et al., (2004)35 also showed that majority 
of  fathers  of  HIV  positive  children  whose  occupation  were  known  to  
semi skilled or unskilled labors .  
Kristi mman et al., 2005, showed agricultural occupation was most 
common among fathers of children who were seropositive for HIV. This higher 
incidence of HIV among the children of semikilled, unskilled and agricultural 
laborers may be attributed to their lack of knowledge and awareness in the 
aspects of modes of transmission and  prevention of HIV. 
MOTHERS OCCUPATION 
Among the mothers of children enrolled in the study, only 19 (14%) 
were working women, mostly getting daily wages. Rest others were house 
wives. All the mothers of ELISA positive children in this study were house 
wives and it was statistically significant. As the fathers’ ELISA status of all the 
children who were seropositive for HIV in this study was not known, no 
comment can be made on the infective partner. Also HIV status statistics of 
both working women and house wives in our setup is not available and hence 
this statistical significance of mothers’ occupation status can be ignored. 
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PARENT’S HIV STATUS 
In this study there was no correlation between HIV status of parents 
with child’s HIV positivity. Tahziba Hussain et al., (2004)34 showed 80% of 
children with HIV positivity had either father or mother HIV positive. R.Lodha 
et al., (1999)26 showed that all the fathers of children who were seropositive 
were seronegative for HIV while few of mothers were elisa positive. P 
Parthasarathy et al36 showed 22% of seropositive children had either father or 
mother positive 
HISTORY OF PREVIOUS BLOOD TRANSFUSION 
This study showed statistically significant correlation between blood  
transfusion and seropositivity. R.Lodha et al., (1999)3 also showed 
contaminated blood transfusion seems to be a source of infection for HIV in 
children in New Delhi and all the transfusions were given for poorly defined 
conditions. R.Dhurrat et al., (2000)26 found higher incidence of HIV among 
thalassemic children who were given multiple blood transfusions. R.Merchant 
et al ., (1997)27 however found that blood transfusion was not a significant risk 
factor.All these studies state that blood transfusion continues to be a significant 
risk factor for HIV transmission. So children should be given blood transfusion 
only under well defined conditions with utmost safety precautions. Though 
PCR can detect the presence of HIV infection in the window period, it cannot 
be routinely used for screening of blood products considering its cost. 
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SYMPTOM  ANALYSIS 
ORAL THRUSH  
STUDY PERCENTAGE 
S.Bavadekar etal (2005)31
R.Lodha et al., (1999)3 
R.Dhurrat et al., (2000)26 
R.Merchant et al ., (1997)27 
Karande et al., (2002)37 
I.shah et al .,(1994)38 
I. E.Modi et al., (1989)39 
This study. 
75% 
36% 
50% 
14% 
80% 
14% 
19% 
25% 
 
This study found that oral thrush is a single significant identifiable risk 
factor for HIV. None of the studies mentioned here have contradicted the above 
finding.  
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WASTING SYNDROME   
STUDY PERCENTAGE 
S.Bavadekar etal (2005)31 
R.Lodha et al., (1999)3 
R.Dhurrat et al., (2000)26 
R.Merchant et al ., (1997)27 
Tovo et al .,(1992)40,41 
Greenberg et al., (1998)42 
Italian register for HIV in 
Children (1994) 43 
This study 
50% 
100% 
48% 
45% 
50% 
90% 
78% 
 
60% 
                         
In the present study wasting syndrome (failure to thrive, Grade III and 
Grade IV PEM) was the other significant identifiable risk factor for HIV other 
than oral thrush and GLA. This finding is supported by all the other studies. 
R.Lodha et al., showed that wasting was a risk factor in all the children in their 
study. 
GENERALISED LYMPHADENOPATHY 
STUDY PERCENTAG
E 
S.Bavadekar etal (2005)31 
R.Lodha et al., (1999)3 
R.Dhurrat et al., (2000)26 
R.Merchant et al ., (1997)27 
Tovo et al .,(1992)40,41 
Greenberg et al., (1998)42 
Italian register for HIV in Children (1994)43 
I.shah et al .,(1994)38 
I. E.Modi et al., (1989)39 
This study. 
50% 
40% 
35% 
23% 
78% 
91% 
91% 
 
26% 
60% 
41.7% 
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HEPATOSPLENOMEGALY AS A RISK FACTOR  
STUDY PERCENTAGE 
R.Dhurrat et al., (2000)26
R.Merchant et al ., (1997)27 
I.shah et al .,(1994)38 
S,R.Daga et al., 30 
This study 
67% 
30% 
30% 
30% 
16% 
 
The lower incidence of HIV seropositivity in patients with 
hepatosplenomegaly in this study may be due to other diseases like malaria, 
typhoid, dengue, hepatitis, cirrhosis of liver etc., that present with 
hepatosplenomegaly are more prevalent in our area. 
EXTRA PULMONARY TUBERCULOSIS 
Study Percentage 
P.Parthasarathy et al36 
S.Bavadekar et al31 
S.R.Daga et al30 
R.Dhurrat et al26 
I.Shah et al38 
R.Merchent et al27 
Tazhiba hussain et al34 
This study 
6% 
20% 
33% 
67% 
30% 
30% 
13% 
16% 
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The present study showed seroprevalance of 16% with extra pulmonary 
TB. 
Tuberculosis is a common problem among children with HIV. The high 
prevalence of tuberculosis among HIV-infected adults leads to increased risk of 
this infection among infected children. Therefore it is essential to monitor these 
children carefully and institute treatment early, since response to treatment is 
good. Since tuberculin test may be negative in a significant proportion of these 
children, one must be careful not to relay solely on this test for screening.  
R.merchent et al., found tuberculosis is one of the most common life 
threatening opportunistic infections among children infected with HIV, and it 
occurs at higher CD4 cell counts when immune deficiency is comparatively 
less advanced Studies from Zambia show that HIV seroprevalence rate is 37% 
amongst children with tuberculosis as compared to 11% amongst those without 
TB.HIV seropositivity was 53% in 12-18 month age group and 14% in 10-14 
yrs old. Unfortunately similar studies from India are lacking. However as the 
disease pattern and socio economic conditions are similar to those in Africa the 
alarmingly high HIV seroprevalence in this study can be explained. Tazhiba 
Hussain et al., showed 13% incidence of HIV among TB patients in pediatric 
age group. 82% of TB patients had a history of positive contact i.e., one of the 
parent were HIV affected. The lower prevalence found in the present study is 
more likely to be the result of different selection criteria. 
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PERSISTANT PNUEMONIA: 
Study Percentage 
R.Dhurrat et al.,26
I.Shah et al.,38 
R.Merchent et al.,27 
I.J.EModi et al.,39 
R.Lodha et al.,3 
This study 
24% 
32% 
32% 
32% 
16% 
8.3% 
 
This lower incidence of HIV as a cause of persistent pneumonia could 
be explained by more common cause like pulmonary TB or foreign body in our 
setup. 
RECURRENT BACTERIAL INFECTION 
 
Study Percentage 
S.R.Daga et al., 199930 
Tovo et al.,1992 40,41 
Greenberg et al., (1999)42 
Italian register for HIV in Children (1994)43 
This study 
26% 
12% 
41% 
26% 
0% 
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Our study showed no correlation between the seropositivity for ELISA 
and recurrent bacterial infections. 
S.Bavadekar et al., (2005) also supported this study by finding no 
correlation between recurrent bacterial infection and seropositivity for ELISA. 
While all other studies were against our finding with respect to recurrent 
bacterial infection, this could be due to varied incidence of RBI in different 
countries. 
PROLONGED FEVER  
Study Percentage 
S.Bavadekar et al31 
I.Shah et al38 
Tovo et al.,1992 40,41 
Greenberg et al., (1999)42 
Italian register for HIV in Children 
(1994)43 
I.J.Emodi39 
R.Lodha et al.,3 
This study 
18 % 
12 % 
43 % 
85 % 
71 % 
51 % 
95 % 
     0 % 
 
In this present study none of the children with prolonged fever were 
seropositive for HIV. This could be due to the fact that in our setup there were 
various other conditions which present with prolonged fever such as malaria, 
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urinary tract infection, TB etc., hence there is no need in routinely screening 
children with prolonged fever for HIV until all other investigations are 
negative. 
CHRONIC DIARRHEA        
Study Percentage 
Italian register for HIV in children43
Tova et al40,41 
R.Lodha et al3 
S.R .Daga et al30 
R.Dhurrat et al26 
R.Merchent et al27 
I.J.Emodi et al39 
Parthasarathy et al36 
The present study 
50% 
30% 
45% 
42% 
30% 
24% 
38% 
4% 
none 
 
The present study could not find any correlation between chronic 
diarrhea and seropositivity for HIV. S.Bavadekar et al also found that chronic 
diarrhea was not a significant risk factor for child being seropositive for HIV 
In our set up children are more top fed along with breast feeding that too 
mostly with feeding bottles, and our area is surrounded by slums with poor 
sanitation facilities and very poor hygiene this could explain the higher 
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incidence of chronic diarrhea in our set up with out the child being seropositive 
for HIV 
E.Sami et al 1994 44showed that diarrhoea lasting for more than 14 days 
is a risk factor for child being sero positive for HIV  
CHRONIC OR PERSISTENT COUGH 
 I.J.Emodi et al39 showed 32%, R.Lodha et al3 showed 86% 
association of chronic cough with HIV. The present study could not find any 
correlation between presence of chronic cough an elisa positivity for HIV 
S.Bavadekar et al also found no correlation between presence of chronic 
cough and elisa positivity for HIV. This could be due to the fact that TB was 
more prevalent in our setup and bronchial asthma was other cause of chronic 
cough in our set up 
CHRONIC PAROTITIS 
R.Dhurrat et al26 found 13% seropositivity rate for HIV amongst 
children with chronic parotitis.R.Merchent et al.,27 and I.Shah et al38 found 
lower seroprevalence in children with chronic parotitisThe present study 
enrolled two children with chronic parotitis but both were sero negative for 
HIV. both were referred as partially treated mumps to us.S.Bavadekar et al also 
found no cases of chronic parotitis.This may be due to the fact that chronic 
parotitis is rare in children whether HIV positive or otherwise 
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GENERALIZED DERMATITIS 
Study Percentage 
S.Bavadekar et al31
I.J.Emodi et al39 
R.Dhurrat et al26 
I.Shah et al38 
S.R.Daga et al30 
The present study 
83% 
37% 
31% 
22% 
10% 
None 
     
The present study could not find many cases of generalized dermatitis 
other than two cases of recurrent herpes zoster and both were seronegative for 
HIV 
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CONCLUSION 
1. The present study found a overall prevalence rate of 9.3% for HIV 
amongst hospitalized children when they are admitted with at least one 
of selected manifestations  
2. The study found oral thrush, generalized lymphadenopathy and wasting 
were single significant risk factor for child being sero positive for HIV 
3. On considering oral thrush an wasting as one group sensitivity and 
specificity increased 
4. The study found that, prolonged fever ,persistent pneumonia,chronic 
cough,chronic diarrhea,recurrent bacterial infection were not the 
significant risk factors for child being sero positive for HIV 
5. Selected manifestations were 58% sensitive and 56% specific between 
the age groups of 31-34 months 
6. There was no correlation between parent occupation or elisa status and 
child’s sero positivity 
7. There was no correlation between gender child’s sero positivity 
MASTER CHART 
 
S.No. AGE  SEX F.Occ. M.Occ. 
HIV 
(M) 
HIV (F) 
PREV 
BT 
GLA HSM
PER. 
PNEU 
MBI. EP TB FEVER  COUGH 
CHR. 
DIARR 
WASTING ORAL THR RBI GENDER 
ELISA 
STATUS 
1 108 2 MASON HW 0 0 0 1 1 0 0 0 0 0 0 0 0 0 0 0 
2 48 1 FARMER HW 0 0 0 0 0 0 1 0 0 0 0 0 0 1 1 2 
3 72 2 FARMER HW 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 2 
4 72 1 COOLEY HW 0 0 1 1 0 0 0 0 0 0 0 1 0 0 0 1 
5 48 1 COOLEY HW 0 0 0 1 1 0 0 0 0 0 0 0 0 0 0 1 
6 42 1 COOLEY HW 0 0 0 1 0 0 0 0 0 0 0 1 0 0 0 1 
7 72 1 COOLEY HW 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 2 
8 18 2 COOLEY HW 0 0 0 1 0 0 0 0 0 0 0 1 0 0 0 1 
9 72 2 COOLEY HW 0 0 0 0 1 0 0 0 0 0 1 1 0 0 0 2 
10 24 1 COOLEY HW 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 2 
11 36 1 COOLEY HW 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 1 
12 66 1 MASON HW 1 1 0 0 1 0 0 0 1 0 0 0 0 0 0 2 
13 84 1 FISHMAN HW 0 0 0 0 0 0 1 1 0 0 0 0 0 0 1 2 
14 24 1 STEEL  
POLISHER 
HW 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 2 
15 30 1 MASON HW 0 0 0 1 0 0 0 0 0 0 0 0 1 0 0 1 
16 12 1 MASON HW 0 0 0 0 0 1 0 0 0 0 0 0 1 1 0 2 
17 96 2 COOLEY HW 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 2 
18 120 1 COOLEY HW 0 0 0 0 0 0 0 1 0 0 0 0 0 1 0 2 
19 108 2 COOLEY HW 0 0 0 1 1 0 0 0 0 0 0 0 0 0 0 2 
20 18 2 COOLEY HW 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 2 
21 24 2 TAILOR HW 0 0 0 0 0 0 1 0 0 0 1 1 0 0 0 2 
22 144 2 BARBER HW 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 2 
23 18 1 TAILOR HW 0 0 0 0 0 0 0 0 0 0 0 1 0 1 0 2 
24 30 2 SALESMAN HW 0 0 1 1 0 1 0 0 0 0 0 1 0 0 0 2 
25 18 2 COOLEY HW 0 0 0 0 0 0 1 0 1 0 0 0 0 0 0 2 
26 36 1 DRIVER HW 1 0 0 0 0 0 0 0 1 0 0 1 0 1 0 2 
27 96 1 COOLEY HW 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 2 
28 48 2 COOLEY HW 0 0 0 1 0 0 1 0 0 0 0 0 0 0 0 2 
29 72 2 SHOP OWNER HW 0 0 0 1 1 0 0 0 0 0 0 0 0 1 0 2 
30 30 1 SHOP OWNER HW 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 2 
31 120 1 PAINTER HW 0 0 0 0 0 1 1 0 0 0 0 0 0 0 0 2 
S.No. AGE  SEX F.Occ. M.Occ. 
HIV 
(M) 
HIV (F) 
PREV 
BT 
GLA HSM
PER. 
PNEU 
MBI. EP TB FEVER  COUGH 
CHR. 
DIARR 
WASTING ORAL THR RBI GENDER 
ELISA 
STATUS 
32 9 2 COOLEY HW 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 2 
33 6 2 COOLEY HW 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 2 
34 9 1 FISHMAN HW 0 0 0 0 1 0 0 0 0 0 0 0 0 1 0 2 
35 15 1 FISHMAN HW 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 2 
36 48 2 COOLEY HW 0 0 0 0 0 0 1 0 0 1 0 0 0 0 0 2 
37 72 1 DRIVER HW 0 0 0 1 0 0 0 1 0 0 0 0 0 0 0 2 
38 84 1 COOLEY HW 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 2 
39 48 1 COOLEY HW 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 2 
40 36 1 COOLEY HW 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 2 
41 36 2 COOLEY HW 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 2 
42 132 1 COOLEY HW 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 2 
43 36 1 COOLEY HW 0 0 0 1 1 0 0 0 0 0 0 0 0 0 0 2 
44 120 2 COOLEY HW 0 0 0 0 0 1 0 1 0 0 0 0 0 0 0 2 
45 4 1 COOLEY HW 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 2 
46 24 2 COOLEY HW 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 2 
47 48 1 STEEL 
POLISHER 
HW 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 2 
48 7 2 COOLEY HW 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 2 
49 8 2 STEEL 
POLISHER 
HW 1 1 0 0 0 0 0 0 0 0 0 1 0 0 0 2 
50 108 1 COOLEY HW 1 1 0 0 0 0 0 0 1 0 0 0 0 0 0 2 
51 12 1 COOLEY COOLEY 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 2 
52 48 1 COOLEY HW 0 0 0 0 1 0 1 0 0 0 0 0 0 0 0 2 
53 108 1 COOLEY COOLEY 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 2 
54 4 1 TAILOR HW 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 2 
55 3 1 STEEL 
POLISHER 
HW 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 2 
56 132 1 COOLEY HW 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 2 
57 18 1 FARMER HW 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 1 
58 36 1 PAINTER HW 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 2 
59 4 1 STEEL 
POLISHER 
HW 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 2 
60 6 1 COOLEY COOLEY 0 0 0 0 1 1 0 0 0 0 0 0 0 0 0 2 
61 120 1 COOLEY COOLEY 0 0 0 1 1 0 0 0 0 0 0 0 0 0 0 2 
62 7 1 COOLEY COOLEY 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 2 
63 48 2 FARMER HW 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 2 
S.No. AGE  SEX F.Occ. M.Occ. 
HIV 
(M) 
HIV (F) 
PREV 
BT 
GLA HSM
PER. 
PNEU 
MBI. EP TB FEVER  COUGH 
CHR. 
DIARR 
WASTING ORAL THR RBI GENDER 
ELISA 
STATUS 
64 36 2 COOLEY HW 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 2 
65 4 2 COOLEY HW 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 2 
66 48 1 COOLEY HW 0 0 0 1 1 0 0 0 0 0 0 0 0 0 0 2 
67 24 2 COOLEY HW 0 0 0 0 1 0 0 1 0 0 0 0 0 0 0 2 
68 3 1 COOLEY HW 1 0 0 0 0 0 0 0 0 0 0 1 0 0 0 2 
69 8 2 COOLEY HW 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 1 
70 5 2 COOLEY HW 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 2 
71 6 1 COOLEY HW 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 2 
72 60 1 TAILOR HW 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 2 
73 30 2 DRIVER HW 0 0 0 0 0 1 0 0 0 0 0 0 1 0 0 1 
74 60 2 COOLEY COOLEY 0 0 0 0 0 1 0 0 0 0 0 0 1 0 0 2 
75 120 2 MASON HW 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 1 
76 48 1 TEA VENDOR HW 0 0 0 1 1 0 0 0 0 0 0 0 0 0 0 2 
77 72 1 COOLEY COOLEY 0 0 0 0 1 0 0 0 1 0 0 0 0 0 0 2 
78 84 1 FISHERMA HW 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 2 
79 9 2 COOLEY HW 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 2 
80 4 1 DRIVER HW 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 2 
81 108 1 CARPENTER COOLEY 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 2 
82 48 1 COOLEY HW 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 2 
83 6 2 COOLEY HW 0 0 0 0 0 0 0 0 0 0 0 1 1 0 0 1 
84 10 1 COOLEY HW 0 0 0 0 0 0 0 0 1 0 0 1 0 0 0 2 
85 36 1 COOLEY COOLEY 0 0 0 0 1 0 0 0 0 0 0 1 0 0 0 2 
86 18 1 COOLEY HW 0 0 0   0 0 0 0 0 0 1 0 0 0 2 
87 48 2 MASON HW 0 0 0 0 0 0 1  0 0 0 0 0 1 0 2 
88 24 2 COOLEY HW 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 2 
89 36 1 COOLEY HW 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 2 
90 96 2 COOLEY HW 0 0 0 0 1 0 0 0 1 0 0 0 0 0 0 2 
91 48 1 COOLEY HW 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 2 
92 12 1 MASON HW 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 2 
93 60 2 COOLEY COOLEY 0 0 0 1 1 0 0 0 0 0 0 0 0 0 0 2 
94 72 2 DRIVER COOLEY 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 2 
95 6 1 COOLEY HW 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 2 
96 48 2 COOLEY HW 0 0 0 0 1 0 0 0 0 0 1 0 0 0 0 2 
97 36 1 COOLEY COOLEY 0 0 0 0 1 0 0 0 0 0 0 1 0 0 0 2 
98 30 1 COOLEY HW 0 0 0 0 1 0 0 0 0 0 0 1 0 0 0 1 
S.No. AGE  SEX F.Occ. M.Occ. 
HIV 
(M) 
HIV (F) 
PREV 
BT 
GLA HSM
PER. 
PNEU 
MBI. EP TB FEVER  COUGH 
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99 4 2 COOLEY HW 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 2 
100 9 2 COOLEY HW 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 2 
101 48 1 COOLEY HW 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 2 
102 72 1 COOLEY COOLEY 0 0 0 1 1 0 0 0 0 0 0 0 0 0 0 2 
103 12 2 COOLEY HW 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 2 
104 32 1 MASON HW 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 2 
105 24 1 COOLEY HW 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 2 
106 120 1 COOLEY HW 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 2 
107 96 1 TAILOR HW 0 0 0 1 1 0 0 0 0 0 0 0 0 0 0 2 
108 52 2 COOLEY HW 0 0 0 0 0 0 0 0  0 0 0 0 0 0 2 
109 18 1 MASON COOLEY 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 2 
110 72 1 COOLEY HW 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 2 
111 6 1 COOLEY HW 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 2 
112 48 2 COOLEY HW 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 2 
113 96 2 COOLEY COOLEY 0 0 0 0 1 0 0 0 1 0 0 0 0 0 0 2 
114 18 2 COOLEY HW 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 2 
115 24 1 COOLEY HW 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 2 
116 4 1 MASON HW 0 0 0 0 0 1 1 0 0 0 0 0 0 0 0 2 
117 90 2 COOLEY HW 0 0 0 0 1 0 0 0 1 0 0 0 0 0 0 2 
118 18 1 COOLEY HW 0 0 0 1 0 0 0 0 1 0 0 0 0 0 0 2 
119 36 2 FISHERMAN HW 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 2 
120 96 1 COOLEY HW 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 2 
121 12 2 COOLEY COOLEY 0 0 0 0 0 0 0 0 1 0 0 1 0  0 2 
122 54 2 TAILOR HW 0 0 0 1 0 0 0 1 0 0 0 0 0 0 0 2 
123 24 1 COOLEY HW 0 0 0 1 1 0 0 0 0 0 0 0 0 0 0 2 
124 90 1 COOLEY COOLEY 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 2 
125 6 1 COOLEY HW 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 2 
126 36 2 COOLEY HW 0 0 0 0 0 0 0 0 1 0 0 0 1 0 0 2 
127 18 2 COOLEY HW 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 2 
128 15 1 MASON HW 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 2 
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